Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Pitfalls and major issues in the histologic diagnosis of peripheral T-cell lymphomas: results of the central review of 573 cases from the T-Cell Project, an international, cooperative study
Indexado
WoS WOS:000436880700030
Scopus SCOPUS_ID:84973402635
DOI 10.1002/HON.2316
Año 2017
Tipo revisión

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Peripheral T-cell lymphomas (PTCLs) comprise a heterogeneous group of neoplasms that are derived from post-thymic lymphoid cells at different stages of differentiation with different morphological patterns, phenotypes and clinical presentations. PTCLs are highly diverse, reflecting the diverse cells from which they can originate and are currently sub-classified usingWorld Health Organization (WHO) 2008 criteria. In 2006 the International T-Cell Lymphoma Project launched the T-Cell Project, building on the retrospective study previously carried on by the network, with the aim to prospectively collect accurate data to improve knowledge on this group of lymphomas. Based on previously published reports from International Study Groups it emerged that rendering a correct classification of PTCLs is quite difficult because the relatively low prevalence of these diseases results in a lack of confidence by most pathologists. This is the reason why the T-Cell Project requested the availability of diagnostic material from the initial biopsy of each patient registered in the study in order to have the initial diagnosis centrally reviewed by expert hematopathologists. In the present report the results of the review process performed on 573 cases are presented. Overall, an incorrect diagnosis was centrally recorded in 13.1% cases, including 8.5% cases centrally reclassified with a subtype eligible for the project and 4.6% cases misclassified and found to be disorders other than T-cell lymphomas; 2.1% cases were centrally classified as T-Cell disorders not included in the study population. Thus, the T-Cell Project confirmed the difficulties in providing an accurate classification when a diagnosis of PTCLs is suspected, singled out the major pitfalls that can bias a correct histologic categorization and confirmed that a centralized expert review with the application of adequate diagnostic algorithms is mandatory when dealing with these tumours. Copyright (C) 2016 John Wiley & Sons, Ltd.

Revista



Revista ISSN
Hematological Oncology 0278-0232

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Hematology
Oncology
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Bellei, Monica Mujer Univ Modena & Reggio Emilia - Italia
Università degli Studi di Modena e Reggio Emilia - Italia
2 Sabattini, Elena Mujer Policlin St Orsola Malpighi - Italia
Alma Mater Studiorum Università di Bologna - Italia
IRCCS Azienda Ospedaliero-Universitaria di Bologna - Italia
3 Pesce, Emanuela A. Mujer Univ Modena & Reggio Emilia - Italia
Università degli Studi di Modena e Reggio Emilia - Italia
4 Ko, Young-Hyeh Mujer Sungkyunkwan Univ - Corea del Sur
SungKyunKwan University, School of Medicine - Corea del Sur
SKKU School of Medicine - Corea del Sur
5 Kim, Won S. Hombre Sungkyunkwan Univ - Corea del Sur
SungKyunKwan University, School of Medicine - Corea del Sur
SKKU School of Medicine - Corea del Sur
6 CABRERA-CONTRERAS, MARIA ELENA Mujer Universidad de Chile - Chile
7 MARTINEZ-CORTA, VIRGINIA ANGELICA Mujer Inst Anat Patol - Chile
Instituto de Anatomía Patologica - Chile
8 Dlouhy, Ivan Hombre HOSP CLIN BARCELONA - España
Hospital Clinic Barcelona - España
9 Paes, Roberto Pinto Hombre Irmandade Santa Casa Misericordia Sao Paulo - Brasil
Chandru - Brasil
10 Barrese, Tomas Hombre Irmandade Santa Casa Misericordia Sao Paulo - Brasil
Chandru - Brasil
11 Vassallo, Jose Hombre UNIV ESTADUAL CAMPINAS - Brasil
Universidade Estadual de Campinas - Brasil
12 Tarantino, Vittoria Mujer Univ Modena & Reggio Emilia - Italia
Università degli Studi di Modena e Reggio Emilia - Italia
13 Vose, Julie M. Mujer UNMC - Estados Unidos
The Nebraska Medical Center - Estados Unidos
14 Weisenburger, Dennis D. Hombre City Hope Natl Med Ctr - Estados Unidos
City of Hope National Med Center - Estados Unidos
15 Ruediger, Thomas Hombre Stadt Klinikum Karlsruhe GGmbH - Suiza
15 Rüdiger, Thomas Hombre Städtischen Klinikum Karlsruhe - Alemania
16 Federico, Massimo Hombre Univ Modena & Reggio Emilia - Italia
Università degli Studi di Modena e Reggio Emilia - Italia
17 Pileri, Stefano A. Hombre IEO Ist Europeo Oncol - Italia
UNIV BOLOGNA - Italia
Istituto Europeo di Oncologia - Italia
Alma Mater Studiorum Università di Bologna - Italia

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
Fondazione Italiana Linfomi (FIL), Alessandria, Italy
Associazione Angela Serra per la Ricerca sul Cancro, Modena, Italy
Fondazione Cassa di Risparmio di Modena, Modena, Italy
SPECTRUM Pharmaceuticals Inc., Irvine, CA, USA

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
This study was supported by grants from the Fondazione Cassa di Risparmio di Modena, Modena, Italy, the Associazione Angela Serra per la Ricerca sul Cancro, Modena, Italy, the Fondazione Italiana Linfomi (FIL), Alessandria, Italy and SPECTRUM Pharmaceuticals Inc., Irvine, CA, USA.

Muestra la fuente de financiamiento declarada en la publicación.